.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018140

« Back to Dashboard
NDA 018140 describes ATIVAN, which is a drug marketed by West-ward Pharms Int and Valeant Intl and is included in two NDAs. It is available from eight suppliers. Additional details are available on the ATIVAN profile page.

The generic ingredient in ATIVAN is lorazepam. There are twelve drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the lorazepam profile page.

Summary for NDA: 018140

Tradename:
ATIVAN
Applicant:
West-ward Pharms Int
Ingredient:
lorazepam
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 018140

Ingredient-typeBenzodiazepines

Suppliers and Packaging for NDA: 018140

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATIVAN
lorazepam
INJECTABLE;INJECTION 018140 NDA West-Ward Pharmaceuticals Corp. 0641-6000 0641-6000-10 10 VIAL in 1 CARTON (0641-6000-10) > 10 mL in 1 VIAL (0641-6000-01)
ATIVAN
lorazepam
INJECTABLE;INJECTION 018140 NDA West-Ward Pharmaceuticals Corp. 0641-6001 0641-6001-25 25 VIAL in 1 CARTON (0641-6001-25) > 1 mL in 1 VIAL (0641-6001-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength4MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Expired Orange Book Patents for NDA: 018140

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
West-ward Pharms Int
ATIVAN
lorazepam
INJECTABLE;INJECTION018140-001Approved Prior to Jan 1, 19824,017,616► subscribe
West-ward Pharms Int
ATIVAN
lorazepam
INJECTABLE;INJECTION018140-002Approved Prior to Jan 1, 19824,017,616► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc